(2026). High-Dose Baricitinib for Severe Alopecia Areata with Suboptimal Response to Conventional Therapy: A Real-World Assessment. Clinical, Cosmetic and Investigational Dermatology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"High-Dose Baricitinib for Severe Alopecia Areata with Suboptimal Response to Conventional Therapy: A Real-World Assessment."
Clinical, Cosmetic and Investigational Dermatology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"High-Dose Baricitinib for Severe Alopecia Areata with Suboptimal Response to Conventional Therapy: A Real-World Assessment."
Clinical, Cosmetic and Investigational Dermatology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.